Tango Therapeutics Ratios (2020-2026) | TNGX

Ratios Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter)
-24.87%-287.73%-382.59%-437.79%-430.69%-419.80%-452.49%-485.74%-141.43%-207.23%-565.57%-585.29%-128.23%-250.82%-913.80%-738.91%-1,220.31%29.50%
EBIT Margin (Quarter)
-25.10%-288.33%-384.60%-440.76%-436.70%-432.41%-476.79%-525.25%-159.25%-238.78%-644.69%-652.99%-148.69%-283.26%-993.68%-788.76%-1,287.87%26.15%
EBITDA Margin (Quarter)
-24.92%-288.82%-398.90%-483.73%-446.98%-427.15%-435.33%-459.66%-137.18%-199.66%-550.47%-592.75%-148.69%-283.26%-993.68%-788.76%-1,287.87%26.15%
Operating Margin (Quarter)
-25.10%-288.33%-384.60%-440.76%-436.70%-432.41%-476.79%-525.25%-159.25%-238.78%-644.69%-652.99%-148.69%-283.26%-993.68%-788.76%-1,287.87%26.15%
Net Margin (Quarter)
-4.21%-288.64%-385.69%-437.79%-430.74%-419.80%-453.28%-485.74%-141.87%-207.45%-566.43%-585.91%-128.56%-251.29%-913.80%-739.54%-1,221.41%29.52%
FCF Margin (Quarter)
-42.53%-317.43%-291.10%-523.88%-552.09%-367.62%-457.14%-610.42%-174.46%-290.26%-509.91%-588.04%-120.39%-283.26%-908.38%-774.26%-1,154.48%-58.58%
Efficiency
Assets Average (Quarter)
167.90M348.84M515.15M485.84M459.96M456.28M450.31M420.12M391.55M403.76M415.38M404.39M393.84M366.93M334.45M295.40M256.10M224.01M304.41M417.24M
Equity Average (Quarter)
56.39M210.15M355.08M332.55M309.53M285.89M261.27M238.37M220.10M244.77M264.85M258.78M256.06M238.42M214.34M183.14M150.85M147.49M253.10M368.84M
Invested Capital (Quarter)
54.89M365.41M344.75M320.36M298.70M273.07M249.48M227.26M212.94M276.60M253.11M264.45M247.67M229.17M199.52M166.76M134.95M160.03M346.18M391.51M
Asset Utilization Ratio (Quarter)
0.250.110.070.070.050.050.060.060.090.090.090.090.110.120.130.140.090.300.200.14
Leverage & Solvency
Equity Ratio (Quarter)
0.330.690.690.680.670.590.570.560.560.650.630.650.650.650.630.610.570.760.870.90
Valuation
Enterprise Value (Quarter)
-50.90M-503.81M-145.59M-449.88M-105.15M-100.88M-60.53M-333.64M-66.91M-59.39M-67.28M-343.60M-322.11M-293.28M-260.48M-216.72M-180.78M-152.81M-112.71M-379.84M
Return Ratios
Return on Sales (Quarter)
0.00%-0.03%-0.04%-0.04%-0.04%-0.04%-0.05%-0.05%-0.01%-0.02%-0.06%-0.06%-0.01%-0.03%-0.09%-0.07%-0.12%0.00%-0.02%-0.02%
Return on Capital Employed (Quarter)
-26.01%-11.86%-12.26%-16.01%-22.19%-25.31%-28.14%-31.65%-33.74%-30.45%-30.90%-34.88%-37.85%-42.42%-49.14%-56.22%-72.79%-53.67%-7.55%-6.84%
Return on Invested Capital (Quarter)
-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%0.00%0.00%0.00%
Return on Equity (Quarter)
-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%